Rational use of psychotropic drugs. II. Antianxiety agents.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001007:Anxiety / Q000097:blood / Q000188:drug therapy*; D001463:Barbiturates / Q000008:administration & dosage / Q000627:therapeutic use; D003975:Diazepam / Q000097:blood / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000627:therapeutic use; D011306:Prescription Fees; D011409:Propylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001463:Barbiturates; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D011409:Propylene Glycols; D011619:Psychotropic Drugs; D003975:Diazepam